chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At 1122 pt. c/o feeling light-headed.  At 1124 BP 148/96, P 85, R 20, SpO2 96%.  Pt. reports feeling warm, dizzy and is currently in remission from prostate cancer.  At 1145 States has not had two BP meds in 1 week.  Does not remember the names of the meds.  Reports has an appointment with PCP on 4/28/2021.  At 1145 states dizziness resolved after resting and drinking water.  Referred to walk-in clinic today to get scripts to re-start BP meds.
Moderate arm pain Shooting pain in armpit sharp headache, body aches , chills Low fever 99-100
Mom described pt developing swelling, redness and hard knot of right thigh at injection site. Began to subside after one day. cool compress was recommended.
nausea; vomiting; This case was reported by a consumer via call center representative and described the occurrence of vomiting in a 63-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced vomiting and nausea. On an unknown date, the outcome of the vomiting and nausea were recovered/resolved.   It was unknown if the reporter considered the vomiting and nausea to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the 1st dose of Shingrix 10 weeks ago.  The patient experienced extreme reaction nausea and vomiting for 6 hours. The patient asked expect the same reaction with the 2nd dose.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: Patient received 0.3 ml of Pfizer vaccine. Patient was advised to wait 10-15 minutes after receiving the vaccine. Within a few minutes, patient passed out. He became conscious a few seconds later. Patient experienced sweating, feeling lightheaded, and some tingling in hands. Capillaries were slow to fill but returned to normal after laying down for a few minutes (<2 seconds). Patient was pale, but pupils reactive and equal, could speak without slurring, lungs and heart sounds clear and normal.
In March I started to loose my appetite and would get sick when eating meats which was all of a sudden. I generally felt off and sick. In April I completely lost the ability to eat meat. I started to loose weight and was having more of throat reflux symptoms, when I swallow food didn't go down smoothly. I thought it was from EOE condition I have. End of April beginning of May I started seeing doctors. Since summer of 2011 I was having left shoulder pain and did physical therapy over 6 months which made my shoulder / neck worse. It was found in September that there was a thyroid nodule and I had my thyroid removed. They found it had grown 1/3 of it's size from may 18th to sept 2nd. I have no history of thyroid cancer in my family. Also 2010-2015 I was on high dose of Rancidine. I still have cancer in my body, I'm not cured of it yet.
Patient developed diffuse urticarial rash 1 week after first dose of Pfizer vaccination. No other known triggers. No prior similar symptoms in the past. No recent illnesses. Lot# for vaccine was EW0169.
muscle sore on upper right part of her back; This is a spontaneous report from contactable consumer (patient).   A 71-years-old female patient received bnt162b2 (Pfizer BioNTech COVID-19 Vaccine), dose 1 via an unspecified route of administration, administered in Arm Left on 17Aug2021 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Patient has been experienced muscle sore on upper right part of her back since 25Aug2021. She received the 1st dose of the vaccine on 17Aug2021 and had it on her left arm-It usually occurs some time in a day but not 24/7. Patient took Ibuprofen once a day that started 2 days ago but skipped today as she will have her 2nd dose on 07Sep2021- Asking if this is a general reaction from the vaccine. Therapeutic measures were taken as a result of muscle sore on upper right part of her back. The outcome of the event was unknown.  The lot number for the vaccine, was not provided and will be requested during follow up.
Advised received first covid vaccine 12/21/2020 w/o issues. Received 2nd Pfizer vaccine on 1/11/21. Within minutes her tongue was tingling with sensation of feeling full-felt funny. 30 min later had frontal/jaw headache. 60 min later chills with goose bumps all over while working (works as resp technician at NMCP). While walking to car, her upper arm and front of thighs hurt as if exercised too much.  Self treated with Advil and tylenol.  --- Next day 1/12 0100am awoke with severe bilateral shoulder joint pain extending to shoulder blades, stabbing abdominal/stomach pain, nausea, urge to vomit.  she returned to sleep but awoke 6am with nausea and severe diarrhea and fatigue.  She c/o nasal congetion, sinus fullness and severe post nasal drip x 24 hours. S/s persisted and left work early now with severe bilateral ankle pain.  She was off Wed/Thursday.  Wed 1/13 her shoulder pains eased but now with severe back pain. Wed evening noted tongue swelling sensation again (has pictures) and took oral benadryl and ice chips.  She went to sleep. Thursday 1/14 bilateral knee pain/joint with increased nausea again - treated with zofran.  Friday 1/15 returned to work, pain in knees made gait wobbly = treated with advil.  Notified ID MD and director on tongue swelling and constantly trying to clear throat = sent to ER where treated with oral decadron and M Toradol for pain. She was sent home with prednisone dose pack and compazine.   Recommended f/u with HCP for further testing to r/o possibility of a mast cell disorder of familial hypertrytassemia due to her history of multiple allergies/insect allergies--
SUSPECTED COVID-19 INFECTION; DOING A LOT OF SLEEPING; EXTREME LOWER BACK PAIN; COULD NOT EAT; PAIN IN THE ARM; SHE WAS REALLY SICK; This spontaneous report received from a patient via a company representative concerned a 33 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included hypertension, alcohol user, and nonsmoker, and other pre-existing medical conditions included the patient had no known allergies and no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 27-JUN-2021 for prophylactic vaccination.  The batch number was not reported and has been requested. No concomitant medications were reported. On JUN-2021, the subject experienced she was really sick. On 28-JUN-2021, the subject experienced extreme lower back pain. On 28-JUN-2021, the subject experienced could not eat. On 28-JUN-2021, the subject experienced pain in the arm. On JUL-2021, the subject experienced doing a lot of sleeping. On 01-JUL-2021, the subject experienced suspected covid-19 infection. Laboratory data included: COVID-19 rapid POC test (NR: not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from extreme lower back pain, could not eat, and pain in the arm, and the outcome of suspected covid-19 infection, doing a lot of sleeping and she was really sick was not reported. This report was non-serious.
Extreme fatigue and lethargy, nausea and body aches and headache  began gradually 3-4 hours after the shot and got worse by evening and all next day. 48 hours after the shot, somewhat better, but still anorexic and headache.
Neck pain; Symptoms given in the other arm were the same but much less intense and of shorter duration/pain, large red circle surrounding site and intense itching; Ten days after my vac. I experienced pain; Large red circle surrounding site; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Neck pain), VACCINATION SITE PRURITUS (Symptoms given in the other arm were the same but much less intense and of shorter duration/pain, large red circle surrounding site and intense itching), VACCINATION SITE PAIN (Ten days after my vac. I experienced pain) and VACCINATION SITE ERYTHEMA (Large red circle surrounding site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 011M20A) for COVID-19 vaccination.     Concurrent medical conditions included Heart disease congenital (Hospoce 2/19/20216 and removed from Hospice june 2017) since 2004, Bowel obstruction (Hospitalized with Diverticuliis for 2 months) since 2015, Anxiety (Taking Alprazolam for past 5 years) since 1960, Asthma (Prescribed use of Breo Ellipta) since 1988, Osteo arthritis knees (Prescribed use of Breo Ellipta) since 1982, Penicillin allergy (Penicillin allergy) and Drug allergy (Lidocaine allergy). Concomitant products included ALPRAZOLAM for Anxiety, FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA) for Asthma, MACROGOL 3350 (MIRALAX) and DOCUSATE SODIUM (STOOL SOFTENER) for Laxative supportive care, ISOSORBIDE MONONITRATE (ISOSORBIDE MONONITE) for Open heart surgery, IBUPROFEN (MOTRIN [IBUPROFEN]) for Osteo arthritis knees.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NECK PAIN (Neck pain), VACCINATION SITE PRURITUS (Symptoms given in the other arm were the same but much less intense and of shorter duration/pain, large red circle surrounding site and intense itching), VACCINATION SITE PAIN (Ten days after my vac. I experienced pain) and VACCINATION SITE ERYTHEMA (Large red circle surrounding site). At the time of the report, NECK PAIN (Neck pain), VACCINATION SITE PRURITUS (Symptoms given in the other arm were the same but much less intense and of shorter duration/pain, large red circle surrounding site and intense itching), VACCINATION SITE PAIN (Ten days after my vac. I experienced pain) and VACCINATION SITE ERYTHEMA (Large red circle surrounding site) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: possitive (Positive) Covid breakthrough illness occurred in mid April.         Patient had a routine doctor appointment 2 days prior for second follow-up vaccination and patient told doctor about reaction and asked if patient should follow through with getting the second shot. that was okay to take benedryl or tylenol if needed.   This case was linked to MOD-2021-036904 (Patient Link).
Mother reported child complained of stomach hurting and tongue itching just after leaving clinic; waited in car in parking lot; became more flushed in face and neck; brought back into clinic and noted to have flushing of head and neck area, hives on arms, back, legs (scattered) given BENADRYL po, vital signs stable; observed for approx 2 hours - flushing and hives were improving.
4.22.21 11:15 - 11:30 AM Injection 11:45 AM - 12:00 PM - Quick onset of Vertigo and  Increased Blood Pressure (Quick Rise from normal pressure to elevated blood pressure) 12:15 PM Nausea, Headache and Fuzzy Vision 1:15 PM Blood Pressure checked at a doctor's visit previously scheduled for this time. Systolic increased by 33 points and Diastolic increased by 10-15 points from my normal. 3:00 PM Quick onset of extreme exhaustion, joint and muscle pain 5:00 PM Melancholy  4.23.21 Symptoms Persisted with acute onset of hand pain on side of injection 4.24.21 Blood Pressure Normalized and most symptoms reduced, except fatigue
This prospective pregnancy case was reported by a consumer and described the occurrence of sore arm (injection site) in a 31-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline) during pregnancy. A physician or other health care professional has not verified this report. The subject's medical history included no previous pregnancies. The subject was not using contraception. The conception was normal. There was no maternal medical history that may have an impact on the outcome of this pregnancy. On 10 December 2012 the subject received a dose of BOOSTRIX (unknown details, right arm) and experienced vaccine exposure during the third trimester of pregnancy. The gestational age at the time of vaccination was calculated to be approximately 29 weeks. Date of last menstrual period was reported as May 2012 with an estimated delivery date reported as 24 February 2013. Relevant test results included an ultrasound at 18 weeks gestation. There was no evidence of a defect from prenatal testing. At the time of the report, the pregnancy was ongoing. On 11 December 2012, 1 day after vaccination with BOOSTRIX, the subject experienced sore arm (injection site). The reporter considered the event to be related to vaccination with BOOSTRIX. The reporter also stated that the event was not the result of transmission of an infectious agent via a medicinal product. Relevant test results included an ultrasound examination at 18 weeks gestation. At the time of reporting the event was unresolved. The consumer reported two cases with events after vaccination with BOOSTRIX. See case A1005930A for details on the other case. 06 May 2013 - No further information provided; patient lost to follow-up.
HEADACHE; FEELING FEVERISH; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: not reported) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced headache. On APR-2021, the subject experienced feeling feverish. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache and feeling feverish was not reported. This report was non-serious.
Temperature range 6°F to 14°F Time frame 80 hours; This spontaneous report was received from an office manager, referring to a 12-months-old patient of unknown gender. The patients' pertinent medical history, current conditions, previous drug reactions or allergies, and concomitant medications were not reported.    On 31-AUG-2020, at the age of 12-months-old, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (formulation, strength, dose, vaccination scheme, route of administration and anatomical site of vaccination were not reported; lot number S004554 which has been verified to be valid, expiration date reported and validated as 14-FEB-2021) as prophylaxis. The vaccine administered experienced a temperature range from 6 degrees Fahrenheit (F) to 14F, for 80 hours, as recorded by a data logger (product storage error). There was no previous temperature excursion.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2009USA007304: US-009507513-2009USA007311:
positive COVID-19 test; positive COVID-19 test; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer reported for a female patient (consumer) of an unspecified age received first dose BNT162B2 (Solution for injection, lot/batch number has been requested) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Patient medical history and concomitant medications were not reported. It was reported that, she got the first dose of the COVID-19 vaccine then tested positive on an unspecified date and would like to know how long to wait to get the second dose of the vaccine since she just got her first dose. Outcome of events was unknown.  Follow-up attempts are completed. No further information is expected.
Sudden onset fatigue/lethargy;  new onset joint pain elbows, finger joints, shoulders;  generalized weakness;  intermittent blurred vision left eye; Vertigo.  All symptoms are sudden onset and concurrent in June 2021.
pt recv vax lt arm paresthesia & weakness of rt hand; auto immun response to an unk virus; median nerve rt forearm damaged;
Dizzy spells; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy spells) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced DIZZINESS (Dizzy spells). At the time of the report, DIZZINESS (Dizzy spells) outcome was unknown.            Concomitant product used was not provided by the reporter.  Treatment information was not provided.     Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Follow-up received on 04-May-2021 included no new information.
This spontaneous case was reported by a consumer and describes the occurrence of SKIN WARM (skin warm) and VACCINATION SITE ERYTHEMA (redness around injection that is 10 cm) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced SKIN WARM (skin warm) and VACCINATION SITE ERYTHEMA (redness around injection that is 10 cm). At the time of the report, SKIN WARM (skin warm) and VACCINATION SITE ERYTHEMA (redness around injection that is 10 cm) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not provided. Treatment information includes ice packs. Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: This follow-up was received on 04-MAY-2021 which updated event outcome as recovered/resolved.
This is a spontaneous report from a Non-contactable physician. The physician reported for a 12-year-old male patient (son). A 12-years-old male patient of an unspecified ethnicity received TRUMENBA, via an unspecified route of administration on an unspecified date at single dose. The patient medical history and concomitant medications were not reported. The patient experienced fatigue on an unknown date, rested on the couch for 4 hours. He later felt better and was back to his previous self the next day without other sequelae.
Red swelling 6x6 cm with nodular swelling of 1 cm at injection site. This site was DPT/acellular.
Observed patient for 20 minutes after injection. No ill effects noted. Approx 4 hrs later, felt faint & lightheaded. Neighbor called rescue squad who went to her residence. According to neighbor, EMS checked her vitals: BP slightly elevated, no inpatient was needed patient to follow up with PCP. Patient history = HBP.
DONOR REPORTED SHE WOKE UP FEELING CONGESTED NAUSEATED HOT AND COLD CHECK TEMPERATURE 100.5 DEGREE. REPORTED TOOK OTC TYLENOL S/S RESOLVED LATER THAT DAY.
Tested positive for Covid-19; A spontaneous report was received from a consumer concerning a 76-years-old male patient who received first dose of Moderna's COVID-19 vaccine (mRNA-1273) and experienced events  tested positive for covid-19/SARS-CoV-2 test positive.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 5 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 010M20A) via unknown route in his left arm for prophylaxis of COVID-19 infection.On 25 Feb 2021, the patient was tested positive for covid-19.No treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of event tested positive for covid-19 was unknown.
Received pneumonia and shingles 7/14/15-developed flu like symptoms hours later, seen in ER next am left without provider seeing due to wait. Now presents with fatigue, myalgias (improving). Racing heart and nasal congestion resolved.
Patient developed very sore arm at injection site, lip swelling and labial swelling which was followed by fever, body aches, chills, followed by blisterin and erosion of mucosal  vaginal tissue.  Required IM steroids x 2,  PO steroids, Diphenhydramine, Pepcid, Percocet, Zytret, and indwelling  foley cath placement which patient wore for 2 weeks
Fever, chills, headache , nausea, body aches, Fatigue A vein was punctured while injecting shot.
Pain and warmth @ injection site approx 10 day after vaccination. Possible local reaction vs. early cellulitis.
Received vaccine on 4/6/2021.  That evening I had severe body aches starting around starting around 18:30pm.  Took 400 mg ibuprofen, drank juices & stayed in bed.  Woke up 4/7/2021 had a bad headache, took more ibuprofen(600 mg).  By around 13:30pm on 4/7/2021, my left quad muscle-upper thigh began severely aching - burning like I had climbed stairs on one leg.  It was hard to walk without severe pain.  Rolled it out with rolling pin, took meloxacam but the pain continued.  By Thursday 4/8/2021 the pain was a little bit less but still ached to move leg at all.  Had no swelling or heat to leg.  Have continued to ice, apply heat, massage leg & take ibuprofen for painful leg.  On a pain scale today-pain is 8
Information has been received from a registered nurse concerning a 19 year old female certified medical assistant who on 30-NOV-2006 splashed hepatitis A virus vaccine inactivated  into her eyes during administration. The medical assistant was complaining of burning and had redness in her eyes. The medical assistant's eyes were flushed with an unspecified solution and "getting better", she was reported to be recovering. There was no product quality complaint involved. No further information was available. Additional information has been requested.